Targeting Notch Signaling with a Notch2/Notch3 Antagonist...

Clinical Cancer Research 2015 / 05 Vol. 21; Iss. 9

Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency

Yen, W.-C., Fischer, M. M., Axelrod, F., Bond, C., Cain, J., Cancilla, B., Henner, W. R., Meisner, R., Sato, A., Shah, J., Tang, T., Wallace, B., Wang, M., Zhang, C., Kapoun, A. M., Lewicki, J., Gurne
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-14-2808
Date:
May, 2015
File:
PDF, 1.65 MB
english, 2015
Conversion to is in progress
Conversion to is failed